tm
Seeing Is Believing
tm
Seeing Is Believing
DSGN is currently covered by 2 analysts with an average price target of $14. This is a potential upside of $4.83 (-10.03%) from yesterday's end of day stock price of $15.56.
Design Therapeutics's activity chart (see below) currently has 13 price targets and 20 ratings on display. The stock rating distribution of DSGN is 75% HOLD and 25% BUY.
Analysts average stock forecasts to be materialized ratio is 44.22% with an average time for these price targets to be met of 303.29 days.
Highest price target for DSGN is $14, Lowest price target is $14, average price target is $14.
Most recent stock forecast was given by from RBC on 10-Mar-2026. First documented stock forecast 20-Apr-2021.
Currently out of the existing stock ratings of DSGN, 3 are a HOLD (75%), 1 are a BUY (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Mar-2026
$14
$0.65 (4.87%)
$13
Hold Since 03-Dec-2025
$14
$0.65 (4.87%)
Hold Since 07-May-2024
$12
$-1.35 (-10.11%)
$42
Hold Since 14-Nov-2023
$5
$-7.16 (-58.88%)
$6
What is DSGN (Design Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DSGN (Design Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DSGN (Design Therapeutics)?
Which analyst is the currently most bullish on DSGN (Design Therapeutics)?
Which analyst is the currently most reserved on DSGN (Design Therapeutics)?
